Trial Profile
Randomized Controlled multi-center Trial for Nursing and Health care associated pneumonia with SBT/ABPC, TAZ/PIPC and DRPM.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Doripenem (Primary) ; Piperacillin/tazobactam (Primary) ; Ampicillin/sulbactam
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Therapeutic Use
- 05 Aug 2015 Status changed from active,no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 09 Jul 2013 Planned End Date 30 Sep 2013 added as reported by University Hospital Medical Information Network - Japan record.
- 09 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.